Unit
- Incidence trends: Melanoma incidence has increased steadily over the past several decades, particularly in fair-skinned populations, with rates rising 3-7% annually in many countries. Australia and New Zealand report the highest incidence rates globally, though European and North American rates are also significant.
- Mortality and survival: While melanoma accounts for a small proportion of skin cancer cases, it causes the majority of skin cancer deaths. Early-stage melanoma has a 5-year survival rate exceeding 98%, but this drops dramatically for metastatic disease to around 27%.
- Geographic variation: Incidence varies significantly by latitude, with higher rates near the equator and in regions with high ambient ultraviolet radiation. However, cultural practices and sunscreen use also influence regional patterns.
- Age and gender differences: Melanoma incidence increases with age, but it is also one of the most common cancers in young adults. Men have higher incidence after age 50 and higher mortality across all stages, partly due to delayed diagnosis.
- Socioeconomic impact: The cost of treating advanced melanoma has risen with new therapies, but early detection and prevention remain cost-effective strategies. Disparities in access to care affect outcomes in underserved populations.
- Public health implications: Rising incidence underscores the need for primary prevention campaigns, screening programs, and improved access to dermatologic care. Health systems are adapting to manage the growing burden.
- Data sources and surveillance: Population-based cancer registries provide critical data for monitoring trends and evaluating prevention efforts. Standardized reporting ensures comparability across regions.
- Future projections: Modeling studies suggest incidence will continue to rise unless prevention efforts intensify. Climate change and ozone depletion may further increase UV exposure.
- UV exposure patterns: Intermittent intense sun exposure, particularly with sunburns in childhood, is a stronger risk factor for melanoma than cumulative exposure. This pattern helps explain the higher incidence in populations with indoor occupations who engage in recreational sun exposure.
- Genetic predisposition: Approximately 5-10% of melanomas occur in families with mutations in genes such as CDKN2A and CDK4. Individuals with fair skin, light hair, blue eyes, and a history of numerous atypical nevi are at significantly increased risk, highlighting the role of host factors.
- Primary prevention effectiveness: Sun protection behaviors, including sunscreen use, protective clothing, and avoiding tanning beds, have been shown to reduce melanoma risk. Public health campaigns in Australia have successfully stabilized incidence in younger age groups, demonstrating the impact of sustained prevention efforts.
Scope of Practice
Role: Public Health Epidemiologist in Cancer Surveillance
Within scope:
- Collecting and analyzing melanoma incidence and mortality data from registries
- Identifying population-level risk factors and disparities
- Recommending prevention strategies based on epidemiological evidence
- Communicating findings to policymakers and healthcare planners
Outside scope:
- Diagnosing individual melanoma cases or managing patient care
- Providing medical advice or treatment recommendations to patients
- Interpreting histopathologic slides or staging tumors
- Prescribing or administering therapies
Regulatory Note
Regulation: Population-based cancer registries must comply with data privacy laws such as HIPAA in the US or GDPR in Europe. Reporting is mandatory in many jurisdictions to ensure accurate surveillance.
World Health Organization, International Agency for Research on Cancer. Global Cancer Observatory, 2024.
Quick Revision
- Melanoma incidence is rising globally, especially in fair-skinned populations.
- Early-stage melanoma has excellent survival; metastatic disease has poor prognosis.
- Risk varies by geography, age, gender, and socioeconomic factors.
- Population-based surveillance is essential for prevention planning.